For instance, in lung cancer, the loss of Keap1 heterozygosity and mutations result in decreased Keap1 expression, leading to the upregulation of Nrf2 expression and the activation of its downstream genes 109, 110. The gene discussed is NFE2L2; the disease is lung carcinoma.